Pharmaceutical industry behaviour and the Trans Pacific Partnership AgreementTrans Pacific Partnership Agreement • March 29th, 2014
Contract Type FiledMarch 29th, 2014This editorial examines trends in pharmaceutical industry conduct and strategy over the past 15–20 years and argues that if the TPPA (based on the US proposals) is successfully prosecuted, it will contribute to adverse health outcomes by increasing costs and reducing access to affordable medicines for New Zealanders. This in turn can be expected to disproportionally affect disadvantaged population groups, including Māori and Pacific peoples.